| Literature DB >> 29593269 |
Anna Sophie Mursch-Edlmayr1, Nikolaus Luft1, Dominika Podkowinski1, Michael Ring1, Leopold Schmetterer2,3,4,5,6, Matthias Bolz7.
Abstract
The purpose of this prospective, case control study was to investigate the differences in optic nerve head blood flow measured with Laser Speckle Flowgraphy (LSFG) between Caucasian patients with normal tension glaucoma and healthy subjects. It included 20 eyes from 20 Caucasian patients with diagnosis of normal tension glaucoma and 20 eyes from age- and sex-matched healthy individuals. In the glaucoma group the antiglaucomatous therapy was paused 3 weeks prior to the investigations. Measurement of optic nerve head blood flow was performed with LSFG. The mean blur rate was obtained for different vascular compartments of the optic nerve head. Parameters for the characterization of pulse-waveform of the mean blur rate were calculated. It was shown that the mean blur rate was significantly lower in the glaucoma group compared to the control group (P < 0.001). The significant differences in the pulse-waveform parameters blow out time (P = 0.028) and flow acceleration time index (P < 0.001) indicate a flatter curve in NTG patients. In conclusion, LSFG can detect differences in optic nerve head blood flow between eyes with normal tension glaucoma and healthy eyes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29593269 PMCID: PMC5871884 DOI: 10.1038/s41598-018-23149-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristics and Mean Blur Rate in normal tension glaucoma group and control group including biometric results. Glaucomatous damage was graded into groups according to the visual field impairment[30].
| Characteristics | NTG Number, mean ± SD | Control group Number, mean ± SD | P Value | |
|---|---|---|---|---|
| Number | 20 | 20 | ||
| Sex | Male | 7 | 7 | |
| Female | 13 | 13 | ||
| Age (years) | 70.9 ± 9.1 | 71.0 ± 8.5 | 0.95 | |
| SBP (mmHg) | 144.0 ± 11.3 | 145.2 ± 11.6 | 0.73 | |
| DBP (mmHg) | 81.8 ± 8.0 | 78.0 ± 7.9 | 0.14 | |
| HR (bpm) | 69.7 ± 13.4 | 72.6 ± 10.5 | 0.45 | |
| MRSE (dpt) | −0.7 ± 1.5 | −0.4 ± 1. 1 | 0.46 | |
| BCVA (LogMAR) | 0.05 ± 0.07 | 0.03 ± 0.01 | 0.6 | |
| AGDs | 1.3 ± 0.73 | — | ||
| PGA | 16 (80%) | |||
| PGA + BB | 3 (15%) | |||
| PGA + BB + AA + CAI | 1 (5%) | |||
| IOP (mmHg) | Under therapy | 12.85 ± 1.9 | ||
| No therapy (After washout) | 15.3 ± 2.2 | 15.6 ± 2.6 | 0.8 | |
| MD (dB) | −9.2 ± 6.5 | −1.46 ± 1.37 | < 0.001* | |
| Glaucoma grade | Mild | 7 (35%) | ||
| Moderate | 6 (30%) | |||
| Severe | 4 (20%) | |||
| NA | 3 (15%) | |||
| cp RNFL(μm) | 67.0 ± 8.5 | 95.5 ± 9.0 | < 0.001* | |
| MBR (AU) | MA | 11.36 ± 2.8 | 16.9 ± 2.9 | < 0.001* |
| MV | 24.9 ± 5.7 | 31.6 ± 5.6 | 0.001* | |
| MT | 6.7 ± 1.6 | 8.9 ± 2.0 | 0.001* |
(NTG) Normal tension glaucoma. (SD) Standard deviation. (MBR) Mean blur rate. (SBP) Systolic blood pressure. (DBP) Diastolic blood pressure. (HR) Heart rate. (bpm) Beats per minute. (BCVA) Best corrected visual acuity. (AGDs) Antiglaucomatous drugs. (PGA) Prostaglandin-analogue monotherapy. (PGA + BB) Combination of prostaglandin analogue and beta blocker. (PGA + BB + AA + CAI) Combination of prostaglandin analogue, beta blocker, alpha agonist and carbonic anhydrase inhibitor. (IOP) Intraocular pressure. (MD) Mean deviation of visual field. (NA) Not applicable. (cpRNFL) Circumpapillary retinal nerve fibre layer. (AU) Aberration units. (MA) MBR in all area of interest. (MV) MBR in area of big vessels. (MT) MBR in area of microvasculature. (*Marks statistical significance).
Differences in waveform parameters describing the curve of mean blur rate in the area of the capillaries (MT).
| Waveform parameters | NTG mean ± SD | Control group mean ± SD | P Value |
|---|---|---|---|
| BOT | 45.83 ± 3.95 | 43.22 ± 3.21 | 0.028* |
| BOS | 71.83 ± 6.31 | 68.52 ± 5.06 | 0.075 |
| Skew | 13.32 ± 1.86 | 14.05 ± 2.48 | 0.3 |
| ATI | 31.79 ± 3.48 | 32.45 ± 2.85 | 0.518 |
| RR | 12.32 ± 0.79 | 12.13 ± 0.71 | 0.427 |
| FR | 13.45 ± 4.43 | 14.79 ± 3.21 | 0.28 |
| FAI | 0.56 ± 0.18 | 0.84 ± 0.27 | 0.001* |
| RI | 0.41 ± 0.07 | 0.45 ± 0.05 | 0.026 |
| Fluctuation | 15.94 ± 3.59 | 18.17 ± 3.31 | 0.048 |
(NTG) Normal tension glaucoma. (SD) Standard deviation. (BOT) Blow out time. (BOS) Blow out score. (ATI) Acceleration time index. (RR) Rising rate. (FR) Falling rate. (FAI) Flow acceleration index. (RI) Resistivity index. Data were adjusted for the heart rate. (*Marks statistical significance).
Figure 1ROC curve for mean blur rate (MBR) in the whole optic nerve head area (MA), in the area of the big vessels (MV) and the microvasculature (MT). An area under the ROC curve (AUROC) of 1.0 represents perfect discrimination, whereas an AUROC of 0.5 can be considered chance discrimination.
Sensitivity of mean blur rate in all compartments at 95% specificity.
| Sensitivity (%) | Cut-off | |
|---|---|---|
| MA | 85 | 13.9 |
| MV | 45 | 31.6 |
| MT | 45 | 8.8 |
(MA) Mean blur rate in all area of interest. (MV) Mean blur rate in area of big vessels. (MT) Mean blur rate in area of microvasculature.
Figure 2Calculation of the pulse-waveform parameters. Top left: Blow out time (BOT). Top center: blowout score (BOS). Top right: skew. Middle left: acceleration time index (ATI). Middle center: rising rate (RR). Middle right: falling rate (FR). Bottom left: the flow acceleration index (FAI). Bottom center: resistivity index (RI). Bottom right: fluctuation, (MOF) mean of fluctuation.